Delivery Order SPE2DB24D2011-SPE2DB26FBNZX
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,088.77. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a non-set-aside award issued through competitive procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) valued at $1,603.56. This firm fixed-price delivery order is scheduled for completion by September 22, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $2,917.12 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a contract value of $2,836.90. The award, made on September 11, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025. This contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,020.12 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The pharmaceutical products will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.56 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 30 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB26FBNZXDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,014.76 for Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on October 29, 2025, with completion scheduled for October 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's broader federal pharmaceutical supply agreements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the DLA Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities to support military healthcare systems globally. The parent IDC serves as a flexible contracting vehicle enabling the company to fulfill federal pharmaceutical procurement needs across multiple therapeutic domains, supporting military personnel, veterans, and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/29/25 |